Feb 11, 2019
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.32 to $0.02.
The split itself did not change the total investment value.
Celldex Therapeutics, Inc. (CLDX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Celldex Therapeutics, Inc. company overviewThe latest split shown was on February 11, 2019. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 2 reverse splits between March 10, 2008 and February 11, 2019.